Horizon Kinetics Medical ETF (MEDX) Research
The Horizon Kinetics Medical ETF (MEDX) is structured to achieve significant long-term growth for investors. It accomplishes this by primarily focusing its investments on cutting-edge, patented pharmaceutical and biologic treatments that are considered first-line therapies. The fund aims to generate profits by recognizing and capitalizing on the inherent, underlying value of these companies, as well as benefiting from impactful advancements in medical science.
Market snapshot
- Symbol
- MEDX
- Price
- $33.88
- Day change
- -1.02%
- Market cap
- $18.5M
- 52-week range
- 26.417-35.455
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Argent Focused Small Cap ETF (ALIL)
- Principal Real Estate Active Opportunities ETF (BYRE)
- DoubleLine Fortune 500 Equal Weight ETF (DFVE)
- Franklin Genomic Advancements ETF (HELX)
- Leuthold Select Industries ETF (LST)
- VanEck Morningstar Global Wide Moat ETF (MOTG)
- Pacer Nasdaq International Patent Leaders ETF (PATN)
- Rayliant SMDAM Japan Equity ETF (RAYJ)
Recent insider activity
- NICHOL GEOFFREY — D-Return (144096 shares) on 2009-09-01
- NICHOL GEOFFREY — D-Return (167159 shares) on 2009-09-01
- NICHOL GEOFFREY — D-Return (110000 shares) on 2009-09-01
- NICHOL GEOFFREY — D-Return (200000 shares) on 2009-09-01
- NICHOL GEOFFREY — D-Return (9010 shares) on 2009-09-01
Open Horizon Kinetics Medical ETF (MEDX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.